Aminoglycosides Flashcards

1
Q

Aminoglycoside options

A

-Amikacin

-Gentamicin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Gentamicin formulations

A
  1. Gentocin- sterile injectable solution (IM, SC, IU but given IV off label)
  2. Otomax, Mometamaxx
    -topical ointments for otitis externa
    -includes an antifungal
  3. Topagen
    -topical spray for dermal lesions
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Amikacin formulations

A

1.Amiglyde-V
-sterile injectable solution
-labelled only for IU use in mares but often given off label IV in small animals and equine

**Generally more potent than Gentomicin.. but narrower spectrum of activity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Neomycin

A

-various calf scour boluses, water soluble powders for food animals
-skin/ear ointments
-antimicrobial preservative in many vaccines

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Apramycin

A

-Apralan oral solution for swine scours caused by E. coli

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Aminoglycasides mechanism of action

A

Bind to bacterial ribosomal 30S subunit
-causes incorrect tRNA translation
-disrupts bacterial protein synthesis
-results in increased bacterial membrane permeability

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Factors allowing for aminogylcosides to access the bacteria

A
  1. Need oxygen so very poor efficacy in anaerobic environment
  2. Local pH
    -basic pH= aminoglycosides non ionized, easier to transport in but can diffuse out
    -acidic pH= Aminoglycosides more ionized, less transport in but then ion trapped
  3. Purulent material in abscesses can inactivate aminoglycosides
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Aminoglycosides spectrum of activity

A
  1. gram -
    -especially enteric bacteria (including pseudomonas)
  2. Activity against staph spp
    -includes some MRSA/MRSP
  3. Some activity against enterococcus, mycobacteria, mycoplasma
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are aminoglycosides not effective against?

A
  1. less activity against strep spp
    *especially amikacin
  2. intracellular pathogens
    -including salmonella
  3. Anaerobes
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Ways Aminoglycosides can become Resistance

A
  1. Plasmid-mediated enzymes degrade aminoglycosides and prevent binding to ribosome 30S subunit
    **most important for determining clinical susceptibility
    NOTE: Amikacin is the last to give out/least effected
  2. decreased permeability = adaptive resistance
  3. Chromosomal resistance
    -changes to 30S binding sites so mutations don’t usually produce clinical resistance
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

First exposure adaptive resistance

A

Bacteria takes up aminoglycosides initially and then there is a decrease in AG uptake for 1-2hours
*lasts up to 16hrs post exposure then partial return of susceptibility

-Resistance accumulates with increasing # of doses

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Dosing to avoid first exposure adaptive resistance

A

Infrequent dosing of high doses
*this decreases the adaptive resistance effect

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Amikacin vs. Gentamicin

A

Amikacin is more potent and broader (more gram negs but decreased Strep activity)
-less effected by bacterial resistance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Oral administration of aminoglycosides

A

Very poor!
-yet often found in calf scour boluses (very leaky gut due to damage= drug residues)
-some absorbed during enteritis or with high doses

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Parenteral administration of aminoglycosides

A

Good absorption IM/SC
-but toxicity concerns so often given IV extralabel

Some systemic absorption IU (label) or IMM (ELDU) doses

Local delivery: hopefully minimal absorption

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Aminoglycosides elimination

A

RENAL
-glomerular filtration
-during renal disease, see decreased GFR and clearance of AG (**DOSE MODIFICATION NEEDED)
-binds to proximal tubule cells

16
Q

PK-PD aminoglycosides

A

CONCENTRATION-DEPENDENT ANTIMICROBIAL

Cmax: MIC>10

-increased trough (low drug conc.) plasma concentration correlates with adverse effects

-long post antibiotic effect

-clinical implication: high dose, but only SID or less is most rational.

16
Q

Vd and elimination rates

A

-Low Vd

-Rapid elimination 1-2hrs… fast from plasma but not in tissues

17
Q

Adverse events of aminoglycosides

A
  1. Nephrotoxicity
  2. Ototoxicity
  3. Neuromuscular blockade
  4. Drug interactions
  5. Drug residues
18
Q

Nephrotoxicity

A

Acute tubular necrosis
**most common

Steps:
AG accumulates in renal proximal tubule cells
1. In tubular lumen, cationic AG binds to negative charged phosphotidylinositol on tubular cells
2. AG enters cell via carrier mediated pinocytosis
3. AG sequestered in lysosomes and eventually they rupture which kills proximal tubule cells

19
Q

Protective conditions of nephrons with aminoglycosides

A
  1. Increase GFR
    -by fluid therapy (HYDRATION)
    -by high protein in diet
  2. SID, high dosing (vs. multiple smaller doses)
    -rapid elimination in filtrate so decrease overall contact
  3. High calcium or protein in diet
    -cations compete with positive charges on aminoglycosides for tubule cell binding
20
Q

Ototoxicity

A

-occurs in the ear affects hearing and/or balance
-same mechanism of nephrotoxicity
-not as noticeable by owners… more of a longer term thing

21
Q

Diuretics impact on nephrotoxicity and ototoxicity

A

Seem to be exacerbated by diuretics (flush out of kidney BUT animal loses urine and is dehydrated which is where the risk comes in)

**Diuretics not recommended BUT fluids are recommended

22
Q

Neuromuscular blockage with aminoglycosides

A

Rare
-related to block of ACh at motor end plate
-treat with calcium

23
Q

Drug interactions with aminoglycosides

A
  1. pH incompatibilities when mixed in same syringe
    *Solution: one drug, one syringe
  2. Synergy with beta-lactams (in vitro only)
    -putting drug categories together does not give you a better outcome BUT it does give you a broader range of spectrum
  3. Avoid using with other nephrotoxic drugs
24
Q

Aminoglycosides in food animals

A

Drug residues occur
-most drug gone from plasma in 1 day
-very slow depletion from the kidney (high even a year later)

*neomycin and gentamicin residue violations are common

25
Q

Detecting peak and trough measurements

A

Peak= taken 0.5-1hr after dose

Trough= sample 8hrs after dose if dosing every 24 hrs

Send to lab. Rare. not really done anymore

26
Q

Monitoring of Nephrotoxicity

A
  1. increased urine gamma glutamyl transferase enzyme and urine [GGT:Creatinine] ratio
    -creatinine is filtered but not excreted or absorbed
    -2-3x baseline of creatinine within 3 days of a nephrotoxic dose (nephrons die)
  2. Proteinuria
    -not a sensitive test; takes a long time; lots of things can cause protein increase in urine
  3. Increased serum urea nitrogen and serum creatinine
    -too long, not seen for 7days and damage is already done
27
Q

How to prevent toxicity from aminoglycosides?

A

-fluids
-SID, high dose

28
Q

Local drug therapy of aminoglycosides

A
  1. REgional perfusion
    -torniquet on, infuse high dose within distal limb
    -intra-osseous or intra-articular
  2. Antimicrobial impregnated beads (PMMA)
    -powder with dose of antimicrobial in beads, sterilized and placed at injection site.
    *might not be great because slow and increased exposure at that side